These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31546717)

  • 1. Rapid Microfluidic Preparation of Niosomes for Targeted Drug Delivery.
    Ag Seleci D; Maurer V; Stahl F; Scheper T; Garnweitner G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing.
    Lo CT; Jahn A; Locascio LE; Vreeland WN
    Langmuir; 2010 Jun; 26(11):8559-66. PubMed ID: 20146467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the potential of silymarin-loaded nanovesicles as an effective drug delivery system for cancer therapy: in vivo, in vitro, and in silico experiments.
    Hajinezhad MR; Roostaee M; Nikfarjam Z; Rastegar S; Sargazi G; Barani M; Sargazi S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):7017-7036. PubMed ID: 38630254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
    Seleci M; Ag Seleci D; Scheper T; Stahl F
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
    Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
    Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-ionic surfactant vesicles as a carrier system for dermal delivery of (+)-Catechin and their antioxidant effects.
    Li D; Martini N; Liu M; Falconer JR; Locke M; Wu Z; Wen J
    J Drug Target; 2021 Mar; 29(3):310-322. PubMed ID: 33044095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer.
    Barani M; Mirzaei M; Torkzadeh-Mahani M; Nematollahi MH
    Daru; 2018 Sep; 26(1):11-17. PubMed ID: 30159762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
    Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
    Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
    Chen S; Hanning S; Falconer J; Locke M; Wen J
    Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of green formulation technique and efficacy estimation on cell line studies for dual anticancer drug therapy with niosomes.
    Khan DH; Bashir S; Correia A; Khan MI; Figueiredo P; Santos HA; Peltonen L
    Int J Pharm; 2019 Dec; 572():118764. PubMed ID: 31628977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niosomes: a controlled and novel drug delivery system.
    Rajera R; Nagpal K; Singh SK; Mishra DN
    Biol Pharm Bull; 2011; 34(7):945-53. PubMed ID: 21719996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic directed formation of liposomes of controlled size.
    Jahn A; Vreeland WN; DeVoe DL; Locascio LE; Gaitan M
    Langmuir; 2007 May; 23(11):6289-93. PubMed ID: 17451256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and
    Khallaf RA; Aboud HM; Sayed OM
    J Liposome Res; 2020 Jun; 30(2):163-173. PubMed ID: 31039651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome and niosome preparation using a membrane contactor for scale-up.
    Pham TT; Jaafar-Maalej C; Charcosset C; Fessi H
    Colloids Surf B Biointerfaces; 2012 Jun; 94():15-21. PubMed ID: 22326648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidic manufacturing of phospholipid nanoparticles: Stability, encapsulation efficacy, and drug release.
    Guimarães Sá Correia M; Briuglia ML; Niosi F; Lamprou DA
    Int J Pharm; 2017 Jan; 516(1-2):91-99. PubMed ID: 27840162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic manufacturing of different niosomes nanoparticles for curcumin encapsulation: Physical characteristics, encapsulation efficacy, and drug release.
    Obeid MA; Khadra I; Albaloushi A; Mullin M; Alyamani H; Ferro VA
    Beilstein J Nanotechnol; 2019; 10():1826-1832. PubMed ID: 31579065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
    Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
    Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.
    Huang Y; Chen J; Chen X; Gao J; Liang W
    J Mater Sci Mater Med; 2008 Feb; 19(2):607-14. PubMed ID: 17619962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
    Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
    Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.